Kenza Health Hub logoGet Started
1 May 2026Injectable drugsSource update: June 2025

Azithromycin Injectable: Dosing and Precautions

Azithromycin injectable guidance for severe macrolide-sensitive infections when oral treatment is not possible.

Also searched as

Azithromycin
Prescription under medical supervision

Source reviewed

June 2025

Guide category

Injectable drugs

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Macrolide antibacterial.

Indications

Macrolide-sensitive severe infections, when oral administration is not possible, such as sepsis and diphtheria.

Forms and strengths, route of administration

  • Powder for injection, in 500 mg vial, dissolved in 4.8 ml of water for injection, for IV infusion in 0.9% sodium chloride or 5% glucose.
  • Do not administer by IV or IM injection.

Dose

Dilute each dose to obtain a final concentration of 2 mg/ml and administer over 60 minutes.

Sepsis

  • Child: 10 to 20 mg/kg, maximum 500 mg, once daily.
  • Adult: 500 mg to 1 g once daily.

Diphtheria

  • Child: 10 to 12 mg/kg, maximum 500 mg, once daily.
  • Adult: 500 mg once daily.

Duration

Change to oral treatment as soon as possible.

Contra-indications, adverse effects, precautions

  • Once reconstituted, the solution must be used immediately; discard any unused open vial.
  • Do not administer to patients with allergy to azithromycin or another macrolide, nor to patients with severe hepatic impairment.
  • Administer with caution to children under 6 weeks of age and to patients with risk factors for QT prolongation.
  • May cause gastrointestinal disturbances, reversible hearing disorders, electrolyte disturbances, QT prolongation, severe hypersensitivity reactions, and life-threatening hepatotoxicity.
  • Avoid combination with drugs that prolong the QT interval.
  • Administer with caution and monitor use in patients taking digoxin.
  • Pregnancy and breast-feeding: no contra-indication.
  • Do not mix with other drugs in the same infusion.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.